Palwasha Asghar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Palwasha Asghar has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Kamil Ahmad Kamil
Chief, Internal Medicine Department Nasrat Bashir Curative Hospital Kandahar Afghanistan
2 shared publications - Sujata Lodh
Department of Medicine, Dr. KNS Memorial Institute of Medical Sciences, Barabanki, Uttar Pradesh, India
2 shared publications - Abdur Rehman
Department of Medicine, King Edward Medical University, Lahore, Pakistan
1 shared publication Alysha Khaliq
Rawalpindi Medical University, Rawalpindi, Pakistan
1 shared publication- Archi Mehta
GMERS Medical College, Gotri, Vadodara, Gujarat, India
1 shared publication Arooj Ihsan Ullah
Fatima Jinnah Medical University, Lahore, Pakistan
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 15 (6) , 2365-2366
Reconsidering the neural signature of medication overuse headache: Addiction and neuroplasticity perspectives
Was not provided for this article.
- 1 June 2026
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 15 (6) , 2365-2366
Open AccessReconsidering the neural signature of medication overuse headache: Addiction and neuroplasticity perspectives
Was not provided for this article.
- Open Access
- 13 May 2026
- Published by Springer Nature in Research Square
Mortality Trends and Demographic Patterns in Unspecified Diabetes Mellitus with Peripheral Circulatory Complications: A CDC WONDER Analysis (1999–2023)
Background Diabetes mellitus(DM) and resulting Peripheral Circulatory Complications(PCC) contribute significantly to mortality. This study aimed to analyze the national trends related to unspecified Diabetes Mellitus with Peripheral Circulatory Complications (ICD code E14.5) among US adults stratified by demographic and geographical parameters. Methods Data were abstracted using the CDC WONDER database. Age-adjusted mortality rates(AAMRs) were calculated, and temporal trends were analyzed using the Join point Regression Program (Version 5.0.2). Annual percentage Changes(APCs) with 95% confidence intervals were calculated. Data were stratified by gender, age group, race/ethnicity, U.S. Census Region, states, and urbanization Status. Results From 1999–2023, 193,818 deaths occurred from unspecified DM with PCC. Overall AAMR declined from 2.6 to 1.3 per 100,000 (APC − 6.3%, 95% CI: -10.53 to -5.70, p < 0.001), with an initial rise during 1999–2001 (APC + 17.52%, 95% CI: 4.04 to 30.94, p < 0.05). Males had consistently higher mortality than females. Adults aged ≥ 65 years bore the highest burden (AAMR 15.05). Racial disparities persisted, with Non-Hispanic Blacks showing disproportionately high rates. Geographically, the South Census Region (AAMR 2.56) and non-metropolitan areas (AAMR 2.5) had elevated mortality. State-level variation was substantial, with the District of Columbia highest (4.0) and Utah lowest (1.2). Inpatient settings (47.8%) and nursing homes (25.1%) were the most common places of death. Sensitivity analysis excluding 2020–2021 confirmed trend robustness (AAPC − 4.11%, p < 0.05). Conclusions Mortality related to unspecified DM with PCC has declined overall in the US over the past two decades, yet disparities persist. High mortality findings in males, older adults, the South Census, and non-metropolitan regions highlight the need for targeted public health interventions in southern and non-metropolitan areas.
- 13 May 2026
- Published by Springer Nature in Research Square
Open AccessMortality Trends and Demographic Patterns in Unspecified Diabetes Mellitus with Peripheral Circulatory Complications: A CDC WONDER Analysis (1999–2023)
Background Diabetes mellitus(DM) and resulting Peripheral Circulatory Complications(PCC) contribute significantly to mortality. This study aimed to analyze the national trends related to unspecified Diabetes Mellitus with Peripheral Circulatory Complications (ICD code E14.5) among US adults stratified by demographic and geographical parameters. Methods Data were abstracted using the CDC WONDER database. Age-adjusted mortality rates(AAMRs) were calculated, and temporal trends were analyzed using the Join point Regression Program (Version 5.0.2). Annual percentage Changes(APCs) with 95% confidence intervals were calculated. Data were stratified by gender, age group, race/ethnicity, U.S. Census Region, states, and urbanization Status. Results From 1999–2023, 193,818 deaths occurred from unspecified DM with PCC. Overall AAMR declined from 2.6 to 1.3 per 100,000 (APC − 6.3%, 95% CI: -10.53 to -5.70, p < 0.001), with an initial rise during 1999–2001 (APC + 17.52%, 95% CI: 4.04 to 30.94, p < 0.05). Males had consistently higher mortality than females. Adults aged ≥ 65 years bore the highest burden (AAMR 15.05). Racial disparities persisted, with Non-Hispanic Blacks showing disproportionately high rates. Geographically, the South Census Region (AAMR 2.56) and non-metropolitan areas (AAMR 2.5) had elevated mortality. State-level variation was substantial, with the District of Columbia highest (4.0) and Utah lowest (1.2). Inpatient settings (47.8%) and nursing homes (25.1%) were the most common places of death. Sensitivity analysis excluding 2020–2021 confirmed trend robustness (AAPC − 4.11%, p < 0.05). Conclusions Mortality related to unspecified DM with PCC has declined overall in the US over the past two decades, yet disparities persist. High mortality findings in males, older adults, the South Census, and non-metropolitan regions highlight the need for targeted public health interventions in southern and non-metropolitan areas.
- Open Access
- 8 May 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3105-3111
National mortality trends associated with the death certificate–reported co-occurrence of malignant neoplasms and bacterial diseases in the United States, 1999–2023: a CDC WONDER retrospective analysis
Background and objectives: Growing evidence suggests that bacterial infectious diseases contribute substantially to morbidity and mortality among individuals with malignant neoplasms. However, data regarding mortality related to the co-occurrence of malignant neoplasms and other bacterial diseases is limited. This study analyzes the national mortality trends for the co-occurrence of malignant neoplasms and other bacterial diseases in the United States from 1999 to 2023. Methods: A retrospective study was conducted using Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research mortality data for individuals aged 15+ to calculate age-adjusted mortality rates (AAMRs) per 100 000 and annual percent change (APC) using joinpoint regression, stratified by year, sex, age, race/ethnicity, urbanization, and geographic regions. Results: From 1999 to 2023, 726 510 deaths were recorded involving malignant neoplasms co-occurring with bacterial diseases. The AAMR slightly declined from 8.14 in 1999 to 7.63 in 2012, followed by a rise to 10.02 in 2023 with an APC of 2.51 (95% confidence interval: 2.14–2.89, P < 0.05). Males had higher mortality rates than females, declining until 2012, then increasing, while female rates were stable before rising after 2013. West exhibited the greatest increase in AAMR. Non-Hispanic Black individuals had the highest absolute AAMRs throughout the study period. Nonmetropolitan areas showed greater increases in AAMRs compared to metropolitan areas. Older age groups, especially those 65 years and above, predominantly contributed to mortality. Conclusion: Despite improvements, mortality from bacterial diseases and malignant neoplasms has increased, particularly affecting older adults, men, racial minorities, and the western region, requiring targeted interventions to reduce disease burden in vulnerable communities.
- 8 May 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3105-3111
Open AccessNational mortality trends associated with the death certificate–reported co-occurrence of malignant neoplasms and bacterial diseases in the United States, 1999–2023: a CDC WONDER retrospective analysis
Background and objectives: Growing evidence suggests that bacterial infectious diseases contribute substantially to morbidity and mortality among individuals with malignant neoplasms. However, data regarding mortality related to the co-occurrence of malignant neoplasms and other bacterial diseases is limited. This study analyzes the national mortality trends for the co-occurrence of malignant neoplasms and other bacterial diseases in the United States from 1999 to 2023. Methods: A retrospective study was conducted using Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research mortality data for individuals aged 15+ to calculate age-adjusted mortality rates (AAMRs) per 100 000 and annual percent change (APC) using joinpoint regression, stratified by year, sex, age, race/ethnicity, urbanization, and geographic regions. Results: From 1999 to 2023, 726 510 deaths were recorded involving malignant neoplasms co-occurring with bacterial diseases. The AAMR slightly declined from 8.14 in 1999 to 7.63 in 2012, followed by a rise to 10.02 in 2023 with an APC of 2.51 (95% confidence interval: 2.14–2.89, P < 0.05). Males had higher mortality rates than females, declining until 2012, then increasing, while female rates were stable before rising after 2013. West exhibited the greatest increase in AAMR. Non-Hispanic Black individuals had the highest absolute AAMRs throughout the study period. Nonmetropolitan areas showed greater increases in AAMRs compared to metropolitan areas. Older age groups, especially those 65 years and above, predominantly contributed to mortality. Conclusion: Despite improvements, mortality from bacterial diseases and malignant neoplasms has increased, particularly affecting older adults, men, racial minorities, and the western region, requiring targeted interventions to reduce disease burden in vulnerable communities.
- Open Access
- 7 April 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
National mortality trends in polyneuropathies and other disorders of the peripheral nervous system in the United States, 1999–2023: a CDC WONDER database analysis
Background: Peripheral neuropathies and other disorders of the peripheral nervous system carry a higher mortality risk due to respiratory failure, autonomic instability, and infections. The prevalence increases with age and due to other comorbid conditions. This study evaluates mortality trends in polyneuropathies and other disorders of the peripheral nervous system in the United States from 1999 to 2023. Methods: This study analyzed publicly available data from the CDC WONDER database (1999 to 2023) using ICD-10 codes for polyneuropathy and other disorders of the peripheral nervous system (G60-G64). Join point regression was used to compute annual percent changes and 95% CIs. Results: 70,080 deaths were reported among individuals aged ≥ 55 years. Most deaths occurred at decedents’ homes (33.0%). AAMR increased from 3.18 in 1999 to 4.96 in 2023 (AAPC: 2.31%; 95% CI: 1.89–2.74%). Males maintained consistently higher AAMR than females. The greatest average CMR was demonstrated by those aged 76–85 + years (average CMR: 8.79 per 100,000 over the study period). Most deaths were observed in NH White individuals (88.5%), while Hispanic or Latino individuals had the lowest deaths (3.90%). The West exhibited the highest AAMR (4.20), and the lowest was observed in the Northeast (2.63). Substantial disparities were observed between metropolitan and non-metropolitan areas and across various states. Conclusion: Polyneuropathy related mortality has demonstrated an upward trend among adults aged ≥ 55 years from 1999 to 2023. significant inconsistencies persist with higher mortality among older adults, males, non-Hispanic white individuals, with regional disparities favoring west. This highlights the necessity of focused public health initiatives and enhanced care accessibility for all populations and areas that are at risk.
- 7 April 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Open AccessNational mortality trends in polyneuropathies and other disorders of the peripheral nervous system in the United States, 1999–2023: a CDC WONDER database analysis
Background: Peripheral neuropathies and other disorders of the peripheral nervous system carry a higher mortality risk due to respiratory failure, autonomic instability, and infections. The prevalence increases with age and due to other comorbid conditions. This study evaluates mortality trends in polyneuropathies and other disorders of the peripheral nervous system in the United States from 1999 to 2023. Methods: This study analyzed publicly available data from the CDC WONDER database (1999 to 2023) using ICD-10 codes for polyneuropathy and other disorders of the peripheral nervous system (G60-G64). Join point regression was used to compute annual percent changes and 95% CIs. Results: 70,080 deaths were reported among individuals aged ≥ 55 years. Most deaths occurred at decedents’ homes (33.0%). AAMR increased from 3.18 in 1999 to 4.96 in 2023 (AAPC: 2.31%; 95% CI: 1.89–2.74%). Males maintained consistently higher AAMR than females. The greatest average CMR was demonstrated by those aged 76–85 + years (average CMR: 8.79 per 100,000 over the study period). Most deaths were observed in NH White individuals (88.5%), while Hispanic or Latino individuals had the lowest deaths (3.90%). The West exhibited the highest AAMR (4.20), and the lowest was observed in the Northeast (2.63). Substantial disparities were observed between metropolitan and non-metropolitan areas and across various states. Conclusion: Polyneuropathy related mortality has demonstrated an upward trend among adults aged ≥ 55 years from 1999 to 2023. significant inconsistencies persist with higher mortality among older adults, males, non-Hispanic white individuals, with regional disparities favoring west. This highlights the necessity of focused public health initiatives and enhanced care accessibility for all populations and areas that are at risk.
- 1 April 2026
- Published by Edizioni Minerva Medica in Journal of Neurosurgical Sciences
- Vol. 70 (2)
Artificial intelligence in diagnostic neurosurgery: promising results and need for rigorous validation
- 1 April 2026
- Published by Edizioni Minerva Medica in Journal of Neurosurgical Sciences
- Vol. 70 (2)
Artificial intelligence in diagnostic neurosurgery: promising results and need for rigorous validation
- 3 March 2026
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 28 (2)
Atypical Misophonia With Psychiatric Comorbidities in a Medical Student
This case highlights the need for enhanced recognition of misophonia, integrated care pathways, and improved mental health infrastructure in low- and middle-income countries.
- 3 March 2026
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 28 (2)
Atypical Misophonia With Psychiatric Comorbidities in a Medical Student
This case highlights the need for enhanced recognition of misophonia, integrated care pathways, and improved mental health infrastructure in low- and middle-income countries.
- Open Access
- 11 February 2026
- Published by Springer Nature in BMC Psychology
- Vol. 14 (1)
Association Between Fear of Failure and Impostor Syndrome Among Medical Students: A Cross-Sectional Study
Imposter syndrome (IS) is a psychological pattern involving persistent self-doubt and fear of being exposed as a “fraud” despite objective achi
- 11 February 2026
- Published by Springer Nature in BMC Psychology
- Vol. 14 (1)
Open AccessAssociation Between Fear of Failure and Impostor Syndrome Among Medical Students: A Cross-Sectional Study
Imposter syndrome (IS) is a psychological pattern involving persistent self-doubt and fear of being exposed as a “fraud” despite objective achi
- Open Access
- 30 January 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 49
A critical appraisal of the MIND trial on minimally invasive surgery for intracerebral hemorrhage
- 30 January 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 49
Open AccessA critical appraisal of the MIND trial on minimally invasive surgery for intracerebral hemorrhage